APO Research
Talk to an analyst

APO RESEARCH · REPORT

Marine Biopharmaceutical

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Marine Biopharmaceutical Market Outlook and Growth Opportunities 2026

19 December 2025197 pages

Choose your research edition.

Industry ResearchMarine Biopharmaceutical Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Marine Biopharmaceutical Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Marine Biopharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Marine Biopharmaceutical Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Marine Biopharmaceutical Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Marine Biopharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Marine Biopharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Marine Biopharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Marine Biopharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Marine Biopharmaceutical market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Marine Biopharmaceutical market include Takeda, Pfizer, GSK, TerSera Therapeutics, Seattle Genetics, Pharma Mar SA, Pelagia (EPAX), Nordic Naturals and GNC, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Marine Biopharmaceutical market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Marine Biopharmaceutical and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Marine Biopharmaceutical revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Marine Biopharmaceutical market.

Marine Biopharmaceutical Segment by Company

Takeda

Pfizer

GSK

TerSera Therapeutics

Seattle Genetics

Pharma Mar SA

Pelagia (EPAX)

Nordic Naturals

GNC

Eisai Co

DSM

Croda

Carlson Labs

BASF

Amway

Marine Biopharmaceutical Segment by Type

Drugs

Health Supplement

Marine Biopharmaceutical Segment by Application

Hospital & Clinic

Pharmacy

Other

Marine Biopharmaceutical Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Marine Biopharmaceutical status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Marine Biopharmaceutical key companies, revenue, market share, and recent developments.

3. To split the Marine Biopharmaceutical breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Marine Biopharmaceutical market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Marine Biopharmaceutical significant trends, drivers, influence factors in global and regions.

6. To analyze Marine Biopharmaceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Biopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Marine Biopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Biopharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Marine Biopharmaceutical industry.

Chapter 3: Detailed analysis of Marine Biopharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Marine Biopharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Marine Biopharmaceutical in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Marine Biopharmaceutical Industry Trends Table 2. Marine Biopharmaceutical Industry Drivers Table 3. Marine Biopharmaceutical Industry Opportunities and Challenges Table 4. Marine Biopharmaceutical Industry Restraints Table 5. Global Marine Biopharmaceutical Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Marine Biopharmaceutical Revenue Share by Company (2021-2026) Table 7. Global Marine Biopharmaceutical Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Marine Biopharmaceutical Key Company Manufacturing Base & Headquarters Table 9. Global Marine Biopharmaceutical Company, Product Type & Application Table 10. Global Marine Biopharmaceutical Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Marine Biopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Drugs Table 15. Significant Companies of Health Supplement Table 16. Global Marine Biopharmaceutical Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Marine Biopharmaceutical Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Marine Biopharmaceutical Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Marine Biopharmaceutical Sales Value Share by Type (2021-2026) Table 20. Global Marine Biopharmaceutical Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital & Clinic Table 22. Significant Companies of Pharmacy Table 23. Significant Companies of Other Table 24. Global Marine Biopharmaceutical Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Marine Biopharmaceutical Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Marine Biopharmaceutical Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Marine Biopharmaceutical Sales Value Share by Application (2021-2026) Table 28. Global Marine Biopharmaceutical Sales Value Share by Application (2027-2032) Table 29. Global Marine Biopharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Marine Biopharmaceutical Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Marine Biopharmaceutical Sales Value Share by Region (2021-2026) Table 32. Global Marine Biopharmaceutical Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Marine Biopharmaceutical Sales Value Share by Region (2027-2032) Table 34. Global Marine Biopharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Marine Biopharmaceutical Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Marine Biopharmaceutical Sales Value Market Share by Country (2021-2026) Table 37. Global Marine Biopharmaceutical Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Marine Biopharmaceutical Sales Value Market Share by Country (2027-2032) Table 39. Takeda Company Information Table 40. Takeda Business Overview Table 41. Takeda Marine Biopharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Takeda Marine Biopharmaceutical Product Portfolio Table 43. Takeda Recent Development Table 44. Pfizer Company Information Table 45. Pfizer Business Overview Table 46. Pfizer Marine Biopharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Pfizer Marine Biopharmaceutical Product Portfolio Table 48. Pfizer Recent Development Table 49. GSK Company Information Table 50. GSK Business Overview Table 51. GSK Marine Biopharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. GSK Marine Biopharmaceutical Product Portfolio Table 53. GSK Recent Development Table 54. TerSera Therapeutics Company Information Table 55. TerSera Therapeutics Business Overview Table 56. TerSera Therapeutics Marine Biopharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. TerSera Therapeutics Marine Biopharmaceutical Product Portfolio Table 58. TerSera Therapeutics Recent Development Table 59. Seattle Genetics Company Information Table 60. Seattle Genetics Business Overview Table 61. Seattle Genetics Marine Biopharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Seattle Genetics Marine Biopharmaceutical Product Portfolio Table 63. Seattle Genetics Recent Development Table 64. Pharma Mar SA Company Information Table 65. Pharma Mar SA Business Overview Table 66. Pharma Mar SA Marine Biopharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Pharma Mar SA Marine Biopharmaceutical Product Portfolio Table 68. Pharma Mar SA Recent Development Table 69. Pelagia (EPAX) Company Information Table 70. Pelagia (EPAX) Business Overview Table 71. Pelagia (EPAX) Marine Biopharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pelagia (EPAX) Marine Biopharmaceutical Product Portfolio Table 73. Pelagia (EPAX) Recent Development Table 74. Nordic Naturals Company Information Table 75. Nordic Naturals Business Overview Table 76. Nordic Naturals Marine Biopharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Nordic Naturals Marine Biopharmaceutical Product Portfolio Table 78. Nordic Naturals Recent Development Table 79. GNC Company Information Table 80. GNC Business Overview Table 81. GNC Marine Biopharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. GNC Marine Biopharmaceutical Product Portfolio Table 83. GNC Recent Development Table 84. Eisai Co Company Information Table 85. Eisai Co Business Overview Table 86. Eisai Co Marine Biopharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Eisai Co Marine Biopharmaceutical Product Portfolio Table 88. Eisai Co Recent Development Table 89. DSM Company Information Table 90. DSM Business Overview Table 91. DSM Marine Biopharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. DSM Marine Biopharmaceutical Product Portfolio Table 93. DSM Recent Development Table 94. Croda Company Information Table 95. Croda Business Overview Table 96. Croda Marine Biopharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Croda Marine Biopharmaceutical Product Portfolio Table 98. Croda Recent Development Table 99. Carlson Labs Company Information Table 100. Carlson Labs Business Overview Table 101. Carlson Labs Marine Biopharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Carlson Labs Marine Biopharmaceutical Product Portfolio Table 103. Carlson Labs Recent Development Table 104. BASF Company Information Table 105. BASF Business Overview Table 106. BASF Marine Biopharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. BASF Marine Biopharmaceutical Product Portfolio Table 108. BASF Recent Development Table 109. Amway Company Information Table 110. Amway Business Overview Table 111. Amway Marine Biopharmaceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Amway Marine Biopharmaceutical Product Portfolio Table 113. Amway Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Marine Biopharmaceutical Product Image Figure 2. Global Marine Biopharmaceutical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Marine Biopharmaceutical Market Size (2021-2032) & (US$ Million) Figure 4. Global Marine Biopharmaceutical Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Drugs Image Figure 8. Health Supplement Image Figure 9. Global Marine Biopharmaceutical Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Marine Biopharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Marine Biopharmaceutical Sales Value Share by Type (2021-2032) Figure 12. Hospital & Clinic Image Figure 13. Pharmacy Image Figure 14. Other Image Figure 15. Global Marine Biopharmaceutical Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Marine Biopharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Marine Biopharmaceutical Sales Value Share by Application (2021-2032) Figure 18. Global Marine Biopharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Marine Biopharmaceutical Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Marine Biopharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 21. North America Marine Biopharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Marine Biopharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Marine Biopharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Marine Biopharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Marine Biopharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Marine Biopharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 27. South America Marine Biopharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Marine Biopharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Marine Biopharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Marine Biopharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs
  • Health Supplement
Applications
  • Hospital & Clinic
  • Pharmacy
  • Other
Companies covered
  • Takeda
  • Pfizer
  • GSK
  • TerSera Therapeutics
  • Seattle Genetics
  • Pharma Mar SA
  • Pelagia (EPAX)
  • Nordic Naturals
  • GNC
  • Eisai Co
  • DSM
  • Croda
  • Carlson Labs
  • BASF
  • Amway

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Marine Biopharmaceutical Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Marine Biopharmaceutical Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Marine Biopharmaceutical Market Dynamics
  1. 2.1 Marine Biopharmaceutical Industry Trends
  2. 2.2 Marine Biopharmaceutical Industry Drivers
  3. 2.3 Marine Biopharmaceutical Industry Opportunities and Challenges
  4. 2.4 Marine Biopharmaceutical Industry Restraints
3 Marine Biopharmaceutical Market by Company
  1. 3.1 Global Marine Biopharmaceutical Company Revenue Ranking in 2025
  2. 3.2 Global Marine Biopharmaceutical Revenue by Company (2021-2026)
  3. 3.3 Global Marine Biopharmaceutical Company Ranking (2024-2026)
  4. 3.4 Global Marine Biopharmaceutical Company Manufacturing Base and Headquarters
  5. 3.5 Global Marine Biopharmaceutical Company Product Type and Application
  6. 3.6 Global Marine Biopharmaceutical Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Marine Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Marine Biopharmaceutical Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Marine Biopharmaceutical Market by Type
  1. 4.1 Marine Biopharmaceutical Type Introduction
  2. 4.1.1 Drugs
  3. 4.1.2 Health Supplement
  4. 4.2 Global Marine Biopharmaceutical Sales Value by Type
  5. 4.2.1 Global Marine Biopharmaceutical Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Marine Biopharmaceutical Sales Value by Type (2021-2032)
  7. 4.2.3 Global Marine Biopharmaceutical Sales Value Share by Type (2021-2032)
5 Marine Biopharmaceutical Market by Application
  1. 5.1 Marine Biopharmaceutical Application Introduction
  2. 5.1.1 Hospital & Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Marine Biopharmaceutical Sales Value by Application
  6. 5.2.1 Global Marine Biopharmaceutical Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Marine Biopharmaceutical Sales Value by Application (2021-2032)
  8. 5.2.3 Global Marine Biopharmaceutical Sales Value Share by Application (2021-2032)
6 Marine Biopharmaceutical Regional Value Analysis
  1. 6.1 Global Marine Biopharmaceutical Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Marine Biopharmaceutical Sales Value by Region (2021-2032)
  3. 6.2.1 Global Marine Biopharmaceutical Sales Value by Region: 2021-2026
  4. 6.2.2 Global Marine Biopharmaceutical Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Marine Biopharmaceutical Sales Value (2021-2032)
  7. 6.3.2 North America Marine Biopharmaceutical Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Marine Biopharmaceutical Sales Value (2021-2032)
  10. 6.4.2 Europe Marine Biopharmaceutical Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Marine Biopharmaceutical Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Marine Biopharmaceutical Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Marine Biopharmaceutical Sales Value (2021-2032)
  16. 6.6.2 South America Marine Biopharmaceutical Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Marine Biopharmaceutical Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Marine Biopharmaceutical Sales Value Share by Country, 2025 VS 2032
7 Marine Biopharmaceutical Country-level Value Analysis
  1. 7.1 Global Marine Biopharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Marine Biopharmaceutical Sales Value by Country (2021-2032)
  3. 7.2.1 Global Marine Biopharmaceutical Sales Value by Country (2021-2026)
  4. 7.2.2 Global Marine Biopharmaceutical Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Marine Biopharmaceutical Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Marine Biopharmaceutical Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Marine Biopharmaceutical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Marine Biopharmaceutical Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Marine Biopharmaceutical Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Marine Biopharmaceutical Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 TerSera Therapeutics
  20. 8.4.1 TerSera Therapeutics Company Information
  21. 8.4.2 TerSera Therapeutics Business Overview
  22. 8.4.3 TerSera Therapeutics Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TerSera Therapeutics Marine Biopharmaceutical Product Portfolio
  24. 8.4.5 TerSera Therapeutics Recent Developments
  25. 8.5 Seattle Genetics
  26. 8.5.1 Seattle Genetics Company Information
  27. 8.5.2 Seattle Genetics Business Overview
  28. 8.5.3 Seattle Genetics Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Seattle Genetics Marine Biopharmaceutical Product Portfolio
  30. 8.5.5 Seattle Genetics Recent Developments
  31. 8.6 Pharma Mar SA
  32. 8.6.1 Pharma Mar SA Company Information
  33. 8.6.2 Pharma Mar SA Business Overview
  34. 8.6.3 Pharma Mar SA Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pharma Mar SA Marine Biopharmaceutical Product Portfolio
  36. 8.6.5 Pharma Mar SA Recent Developments
  37. 8.7 Pelagia (EPAX)
  38. 8.7.1 Pelagia (EPAX) Company Information
  39. 8.7.2 Pelagia (EPAX) Business Overview
  40. 8.7.3 Pelagia (EPAX) Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pelagia (EPAX) Marine Biopharmaceutical Product Portfolio
  42. 8.7.5 Pelagia (EPAX) Recent Developments
  43. 8.8 Nordic Naturals
  44. 8.8.1 Nordic Naturals Company Information
  45. 8.8.2 Nordic Naturals Business Overview
  46. 8.8.3 Nordic Naturals Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nordic Naturals Marine Biopharmaceutical Product Portfolio
  48. 8.8.5 Nordic Naturals Recent Developments
  49. 8.9 GNC
  50. 8.9.1 GNC Company Information
  51. 8.9.2 GNC Business Overview
  52. 8.9.3 GNC Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GNC Marine Biopharmaceutical Product Portfolio
  54. 8.9.5 GNC Recent Developments
  55. 8.10 Eisai Co
  56. 8.10.1 Eisai Co Company Information
  57. 8.10.2 Eisai Co Business Overview
  58. 8.10.3 Eisai Co Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Eisai Co Marine Biopharmaceutical Product Portfolio
  60. 8.10.5 Eisai Co Recent Developments
  61. 8.11 DSM
  62. 8.11.1 DSM Company Information
  63. 8.11.2 DSM Business Overview
  64. 8.11.3 DSM Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DSM Marine Biopharmaceutical Product Portfolio
  66. 8.11.5 DSM Recent Developments
  67. 8.12 Croda
  68. 8.12.1 Croda Company Information
  69. 8.12.2 Croda Business Overview
  70. 8.12.3 Croda Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Croda Marine Biopharmaceutical Product Portfolio
  72. 8.12.5 Croda Recent Developments
  73. 8.13 Carlson Labs
  74. 8.13.1 Carlson Labs Company Information
  75. 8.13.2 Carlson Labs Business Overview
  76. 8.13.3 Carlson Labs Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Carlson Labs Marine Biopharmaceutical Product Portfolio
  78. 8.13.5 Carlson Labs Recent Developments
  79. 8.14 BASF
  80. 8.14.1 BASF Company Information
  81. 8.14.2 BASF Business Overview
  82. 8.14.3 BASF Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BASF Marine Biopharmaceutical Product Portfolio
  84. 8.14.5 BASF Recent Developments
  85. 8.15 Amway
  86. 8.15.1 Amway Company Information
  87. 8.15.2 Amway Business Overview
  88. 8.15.3 Amway Marine Biopharmaceutical Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Amway Marine Biopharmaceutical Product Portfolio
  90. 8.15.5 Amway Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst